77 related articles for article (PubMed ID: 9588865)
1. The immunological co-adjuvant action of liposomal interleukin-2: the role of mode of localisation of the cytokine and antigen in the vesicles.
Gursel M; Gregoriadis G
J Drug Target; 1998; 5(2):93-8. PubMed ID: 9588865
[TBL] [Abstract][Full Text] [Related]
2. Primary immune response to liposomal tetanus toxoid in mice: the effect of mediators.
Davis D; Gregoriadis G
Immunology; 1989 Oct; 68(2):277-82. PubMed ID: 2509329
[TBL] [Abstract][Full Text] [Related]
3. Liposomes as adjuvants with immunopurified tetanus toxoid: influence of liposomal characteristics.
Davis D; Gregoriadis G
Immunology; 1987 Jun; 61(2):229-34. PubMed ID: 3596639
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-15 acts as an immunological co-adjuvant for liposomal antigen in vivo.
Gursel M; Gregoriadis G
Immunol Lett; 1997 Mar; 55(3):161-5. PubMed ID: 9161882
[TBL] [Abstract][Full Text] [Related]
5. Mannose-mediated targeted immunoadjuvant action of liposomes.
Garcon N; Gregoriadis G; Taylor M; Summerfield J
Immunology; 1988 Aug; 64(4):743-5. PubMed ID: 3169846
[TBL] [Abstract][Full Text] [Related]
6. Liposomes as adjuvants with immunopurified tetanus toxoid: the immune response.
Davis D; Davies A; Gregoriadis G
Immunol Lett; 1987 Apr; 14(4):341-8. PubMed ID: 3583325
[TBL] [Abstract][Full Text] [Related]
7. Liposomes as immunological adjuvants: antigen incorporation studies.
Gregoriadis G; Davis D; Davies A
Vaccine; 1987 Jun; 5(2):145-51. PubMed ID: 3604394
[TBL] [Abstract][Full Text] [Related]
8. Stimulating role of toxoids-laden liposomes in oral immunization against diphtheria and tetanus infections.
Mirchamsy H; Manhouri H; Hamedi M; Ahourai P; Fateh G; Hamzeloo Z
Biologicals; 1996 Dec; 24(4):343-50. PubMed ID: 9088551
[TBL] [Abstract][Full Text] [Related]
9. Anti-tumor vaccine adjuvant effects of IL-2 liposomes in mice immunized against MCA-102 sarcoma.
Sencer SF; Rich ML; Katsanis E; Ochoa AC; Anderson PM
Eur Cytokine Netw; 1991; 2(5):311-8. PubMed ID: 1804322
[TBL] [Abstract][Full Text] [Related]
10. Liposomal formulations of synthetic MUC1 peptides: effects of encapsulation versus surface display of peptides on immune responses.
Guan HH; Budzynski W; Koganty RR; Krantz MJ; Reddish MA; Rogers JA; Longenecker BM; Samuel J
Bioconjug Chem; 1998; 9(4):451-8. PubMed ID: 9667946
[TBL] [Abstract][Full Text] [Related]
11. Liposome-entrapped T-cell peptide provides help for a co-entrapped B-cell peptide to overcome genetic restriction in mice and induce immunological memory.
Gregoriadis G; Wang Z; Barenholz Y; Francis MJ
Immunology; 1993 Dec; 80(4):535-40. PubMed ID: 7508417
[TBL] [Abstract][Full Text] [Related]
12. Immune response mediated by liposome-associated protein antigens. II. Comparison of the effectiveness of vesicle-entrapped and surface-associated antigen in immunopotentiation.
Shek PN; Sabiston BH
Immunology; 1982 Dec; 47(4):627-32. PubMed ID: 6754583
[TBL] [Abstract][Full Text] [Related]
13. Lipid vesicle-entrapped influenza A antigen modulates the influenza A-specific human antibody response in immune reconstituted SCID-human mice.
Walker W; Brewer JM; Alexander J
Eur J Immunol; 1996 Jul; 26(7):1664-7. PubMed ID: 8766578
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of antitumor activity of polyethylene glycol-coated liposomal doxorubicin with soluble and liposomal interleukin 2.
Cabanes A; Even-Chen S; Zimberoff J; Barenholz Y; Kedar E; Gabizon A
Clin Cancer Res; 1999 Mar; 5(3):687-93. PubMed ID: 10100723
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant properties of non-phospholipid liposomes (Novasomes) in experimental animals for human vaccine antigens.
Gupta RK; Varanelli CL; Griffin P; Wallach DF; Siber GR
Vaccine; 1996 Feb; 14(3):219-25. PubMed ID: 8920703
[TBL] [Abstract][Full Text] [Related]
16. Negatively charged liposomes as immunological adjuvant for tetanus and diphtheria toxoids.
Popescu C; Durbaca S; Ivanov D
Roum Arch Microbiol Immunol; 1998; 57(3-4):255-61. PubMed ID: 11845437
[TBL] [Abstract][Full Text] [Related]
17. Co-administration of polyphosphazenes with CpG oligodeoxynucleotides strongly enhances immune responses in mice immunized with Hepatitis B virus surface antigen.
Mutwiri G; Benjamin P; Soita H; Babiuk LA
Vaccine; 2008 May; 26(22):2680-8. PubMed ID: 18430493
[TBL] [Abstract][Full Text] [Related]
18. The immunological adjuvant and vaccine carrier properties of liposomes.
Gregoriadis G
J Drug Target; 1994; 2(5):351-6. PubMed ID: 7704478
[TBL] [Abstract][Full Text] [Related]
19. Liposome adjuvants prepared from the total polar lipids of Haloferax volcanii, Planococcus spp. and Bacillus firmus differ in ability to elicit and sustain immune responses.
Sprott GD; Dicaire CJ; Gurnani K; Deschatelets LA; Krishnan L
Vaccine; 2004 Jun; 22(17-18):2154-62. PubMed ID: 15149772
[TBL] [Abstract][Full Text] [Related]
20. Liposomes as immunological adjuvants for tetanus vaccine.
Popescu C; Durbaca S; Ivanov D
Roum Arch Microbiol Immunol; 1998; 57(3-4):263-9. PubMed ID: 11845438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
